Relationship between pharmacokinetic and pharmacodynamic behaviour of bufuralol and its metabolite Ro 3-7410 in hypertensive patients.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D004983:Ethanolamines / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006900:Hydroxylation; D006973:Hypertension / Q000503:physiopathology*; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D005082:Physical Exertion
D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; C038122:Ro 3-7410; C010831:bufuralol